“Fewer than 1% of patients taking the drug needed to be hospitalized and no one died. In the comparison group, 7% were hospitalized and there were seven deaths.” So promising that they halted the trial early. Pfizer, like Merck, *must* allow cheap generics for LMIC. No excuses.https://twitter.com/AP/status/1456576002457575427 …
-
-
Let me know how this proposed moratorium works out! <ducking>
Thanks. Twitter will use this to make your timeline better. UndoUndo
-
-
-
I think its interesting that in a year and a half we have two medications with vastly different actions (Pfizer targets a SARS protease, Merck is an RNA analog that gets improperly incorporated and mutates the virus into non viability). This is truly amazing.
-
it is, tho ofc both these medications were not designed from scratch in a year and a half. Pfizer's was being looked at against SARS in early 2000s; Merck's was first tested against coronaviruses in 2015 (and initially developed earlier than that). Always the long backstory!
End of conversation
New conversation -
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.
Folks! Not everyone responds well to vaccines—millions of immunocompromised people, to start with. It’s an unalloyed good to have more tools. This is great news!